Comparing Evolocumab vs Vascepa
| Evolocumab | Vascepa (icosapent) |
|
|---|
| Evolocumab | Vascepa (icosapent) |
|
|||||||
|---|---|---|---|---|---|---|---|---|---|
|
Prescription only
Prescribed for High Cholesterol - Familial Heterozygous, Cardiovascular Risk Reduction, High Cholesterol - Familial Homozygous, High Cholesterol. Evolocumab may also be used for purposes not listed... View more |
Prescription only
Vascepa is a prescription, high-purity eicosapentaenoic acid (EPA - a type of omega-3 fatty acid), that may be used to lower the risk of cardiovascular disease in people with high triglyceride levels... View more |
Related suggestions Cardiovascular Risk Reduction
|
|||||||
| More about Evolocumab | More about Vascepa (icosapent) | ||||||||
| Ratings & Reviews | |||||||||
|
Evolocumab has an average rating of 5.3 out of 10 from a total of 700 ratings on Drugs.com. 39% of reviewers reported a positive effect, while 45% reported a negative effect. |
Vascepa has an average rating of 5.7 out of 10 from a total of 119 ratings on Drugs.com. 45% of reviewers reported a positive effect, while 40% reported a negative effect. |
||||||||
| Side Effects Experienced by Users Side effects are reported in Drugs.com user reviews and not clinically verified. | |||||||||
View all Evolocumab side effects |
View all Vascepa side effects |
||||||||
| Drug Class | |||||||||
| Generic Availability | |||||||||
|
N/A |
|||||||||
| Pricing and Coupons * Prices are without insurance | |||||||||
|
We could not find an exact match for this medicine. Try searching the Price Guide directly. |
View all Vascepa prices |
||||||||
| Dosage Forms | |||||||||
|
N/A |
|
||||||||
| Brand Names | |||||||||
| Repatha |
N/A |
||||||||
| Half Life Drug half-life is the time required for plasma concentration to reduce to half its original value. | |||||||||
|
408 hours |
89 hours |
||||||||
| CSA Schedule 1 View glossary of CSA terms | |||||||||
|
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||
| Pregnancy Category | |||||||||
|
Summary unavailable. See the full pregnancy warnings document. |
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
||||||||
| Drug Interactions | |||||||||
|
A total of 2 drugs are known to interact with Evolocumab:
|
A total of 76 drugs are known to interact with Vascepa:
|
||||||||
| Alcohol/Food/Lifestyle Interactions | |||||||||
|
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
||||||||
| Disease Interactions | |||||||||
|
No known disease interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
|||||||||
| First Approval Date | |||||||||
|
N/A |
July 26, 2012 |
||||||||
| WADA Class View classifications | |||||||||
|
N/A |
N/A |
||||||||
| More Information | |||||||||
| Patient Resources | |||||||||
| Professional Resources | |||||||||
| Related Treatment Guide | |||||||||
1 The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.